Market Size of United Kingdom Self-Monitoring Blood Glucose Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Market Size (2024) | USD 273.34 Million |
Market Size (2029) | USD 345.55 Million |
CAGR (2024 - 2029) | 4.80 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
UK Self-Monitoring Blood Glucose Market Analysis
The United Kingdom Self-Monitoring Blood Glucose Market size is estimated at USD 273.34 million in 2024, and is expected to reach USD 345.55 million by 2029, growing at a CAGR of 4.80% during the forecast period (2024-2029).
The COVID-19 pandemic showed that diabetes needs a lot more attention if we don't want the infection to cause problems that aren't necessary or fair. According to Diabetes UK, in adults with diabetes, there were certain factors that increased the risk of serious illness, like being older, having a high HbA1c, or having a history of diabetes-related complications, along with BMI and ethnicity. According to the 2021 article "Assessment of the effect of the COVID-19 pandemic on UK HbA1c testing: implications for diabetes management and diagnosis," there was evidence that people with prediabetes, obesity, and other causes of dysglycemia were also more likely to have worse outcomes after getting SARS-CoV-2.
Blood glucose monitoring increases patients' awareness of glucose values, which supports healthy lifestyle choices. Blood Glucose Monitoring values help in providing feedback and guidance on how to make health behavior changes when needed. Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. Appropriate and timely monitoring of blood glucose allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications.
Innovative technologies, such as digital health apps that show and summarize each person's blood glucose readings and add other relevant data like insulin doses, meals or snacks, and physical activity, can help people better manage their own diabetes while reducing the burden of the disease and improving care overall. Integration of blood glucose monitoring with insulin calculators, automated insulin titration software, and remote coaching are all new developments that give patients with poorly controlled diabetes the extra help they need to improve critical outcomes, which will improve the market's prospects in the years to come.
UK Self-Monitoring Blood Glucose Industry Segmentation
Diabetic patients can measure their own blood sugar levels using a glucometer, test strips, and lancets by self-monitoring their blood glucose. Based on the readings, patients can adjust or check the effect of their treatment. The United Kingdom self-monitoring blood glucose market is segmented into components (glucometer devices, test strips, and lancets). The report offers the value (in USD million) and volume (in million units) for the above segments.
Component (Value and Volume, 2017 - 2028) | |
Glucometer Devices | |
Test Strips | |
Lancets |
United Kingdom Self-Monitoring Blood Glucose Market Size Summary
The United Kingdom self-monitoring blood glucose market is poised for growth, driven by the increasing prevalence of diabetes and the rising awareness of its management through government initiatives and technological advancements. The market is characterized by a moderate level of fragmentation, with key players such as Abbott, LifeScan, F. Hoffmann-La Roche AG, and Ascensia holding significant shares. The integration of innovative technologies, including digital health apps and advanced glucometers, is enhancing the management of diabetes by providing patients with real-time feedback and guidance on their blood glucose levels. These developments are expected to improve health outcomes and reduce the burden of diabetes-related complications, thereby boosting the market's prospects over the forecast period.
The glucometers segment is anticipated to experience the highest growth rate, attributed to the increasing adoption of these devices in home care settings and the growing preference for home-based self-monitoring. The National Health Service (NHS) in England plays a crucial role in supporting diabetes management through remote consultations and educational programs, which complement traditional healthcare services. The National Service Framework (NSF) program and the Association of British HealthTech Industries (ABHI) are also contributing to the improvement of diabetes care services by setting standards and fostering collaboration among health technology companies. These efforts, combined with the ongoing innovation in medical technology, are expected to drive the expansion of the self-monitoring blood glucose market in the United Kingdom.
United Kingdom Self-Monitoring Blood Glucose Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.3 Market Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products and Services
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Component (Value and Volume, 2017 - 2028)
-
2.1.1 Glucometer Devices
-
2.1.2 Test Strips
-
2.1.3 Lancets
-
-
United Kingdom Self-Monitoring Blood Glucose Market Size FAQs
How big is the United Kingdom Self-Monitoring Blood Glucose Market?
The United Kingdom Self-Monitoring Blood Glucose Market size is expected to reach USD 273.34 million in 2024 and grow at a CAGR of 4.80% to reach USD 345.55 million by 2029.
What is the current United Kingdom Self-Monitoring Blood Glucose Market size?
In 2024, the United Kingdom Self-Monitoring Blood Glucose Market size is expected to reach USD 273.34 million.